Replies to post #16370 on Vilacto Bio Inc. (fka VIBI)

[stervc]

VIBI: This part could help fight COVID-19...

I'm sure if I see this, the management team of VIBI has got to see this too. This part from that article regarding their patented technology could be something significant towards the fight against COVID-19:

https://microcapdaily.com/inside-scoop-on-vilacto-bio-inc-otcmkts-vibi/122822/
The Company recently announced it has revealed the initial five areas of development for its new LACTOACTIVE iTHER® compound. These include a bio-injection that could be useful in preventing metastasis of malignant tumor cells in cancer treatment due to the hydrocolloid potent (HA). An inhaler spray to prevent recurrent upper respiratory tract infections (based on a 2016 study. A vaccine injection for nanoparticle antibody source for a vaccine producer or a new variant of gelatin capsules for patients with arthritis and other joint inflammation with fewer side effects – especially hypertension if people with diabetes – than Glucosamine.

LACTOACTIVE iTHER® is a new LACTOACTIVE variant that combines potent immune-system enhancement with a proven nanoparticle drug delivery system. These development programs are part of Vilacto Bio’s LACTOACTIVE iTHER® plan to form strategic partnerships with other biotech firms and become the “go-to” partner for enhancing new immunotherapy and vaccine solutions with its refined-colostrum compound “weaponized” as a nanomedicine.

v/r
Sterling